10X Genomics Inc Class A (TXG)
EBITDA Growth
-119.25%
Quarterly · Period ending:
TXG EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-119.25%period ending
Latest reported-119.25%period ending
TXG Quarterly EBITDA YoY % (87.66% → -119.25%)
Year-over-year change
High-resolution chart · PNG
TXG ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -119.2515% | |
| 96.0451% | |
| 268.0162% | |
| 32.6564% | |
| 278.2069% | |
| 48.8382% | |
| -8.405% | |
| 70.5116% | |
| 46.4498% | |
| -12.894% | |
| -346.4295% | |
| -152.5404% | |
| 11.5652% | |
| -22.1131% | |
| 7.5485% | |
| -247.4547% | |
| -2,057.6112% | |
| -658.7757% | |
| 97.9022% | |
| 84.7405% | |
| 92.6739% | |
| 72.1975% | |
| -12,533.741% | |
| -776.2635% | |
| -245.7341% | |
| -746.068% | |
| 95.7363% | |
| 53.3333% | |
| -131.6501% | |
| 87.6606% |